Condition: Myasthenia Gravis · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic \[PD\]) when given as an injection under the skin (subcutaneous) compared to when given through a vein (intravenous) in participants with gMG.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Neuromuscular Research Center and Clinic | Paradise Valley, Arizona, United States | Recruiting |
| HonorHealth Neurology | Scottsdale, Arizona, United States | Completed |
| University of Southern California | Los Angeles, California, United States | Completed |
| Stanford University | Palo Alto, California, United States | Completed |
| Care Access Research | Pasadena, California, United States | Recruiting |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| FM Clinical Research, LLC South Florida Neurology Associates, P. A. | Boca Raton, Florida, United States | Recruiting |
| University of Florida Health Jacksonville | Jacksonville, Florida, United States | Completed |
| Medsol Clinical Research Center Inc | Port Charlotte, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Augusta University | Augusta, Georgia, United States | Completed |
+ 100 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04951622